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5 
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7 
8 Abstract 
9 
10 
11 
12 
13 The ability to compare published group-level estimates of objectively measured 
14 
15 
16 moderate-to-vigorous physical activity (MVPA) across studies continues to increase in 
17 
18 difficulty. The objective of this study was to develop conversion equations and 
19 
20 
demonstrate their utility to compare estimates of MVPA derived from the wrist and hip. 
22 
23 Data from three studies of youth (N = 232, 9-12yrs, 50% boys) who concurrently wore a 
24 
25 
hip-worn ActiGraph and a wrist-worn GENEActiv for 7-days. ActiGraph hip count data 
26 
27 
28 were reduced using four established cutpoints: Evenson, Pate, Puyau, and Freedson 
29 
30 3MET. Wrist accelerations were reduced using the Hildebrand MVPA 200 mg threshold. 
31 
32 
33 Conversion equations were developed on a randomly selected subsample of 132 youth. 
34 
35 Equations were cross-validated and absolute error, absolute percent error, and modified 
36 
37 
Bland-Altman plots were evaluated for conversion accuracy. Across equations R2adj was 
39 
40 0.51-0.56 with individual-level absolute error in minutes ranging from 7 (wrist-to-hip 
41 
42 
Puyau) to 14.5 minutes (wrist-to-hip Freedson 3MET) and absolute percent differences 
43 
44 
45 ranging from 13.9%-24.5%. Group-level cross-validation to convert hip-to-wrist MVPA 
46 
47 resulted in average absolute percent errors ranging from 3.1%-4.9%. Conversion of wrist- 
48 
49 
50 to-hip MVPA resulted in average absolute percent errors ranging from 3.0%-10.0%. We 
51 
52 recommend the use of these equations to compare published estimates of MVPA between 
53 
54 
the wear-site cut-point combinations presented. 
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4 Introduction 
5 
6 
7 
8 
9 
As the body of scientific studies that describe or intervene on youth physical activity 
10 
11 
12 continues to expand, there is a growing need to be able to make comparisons across 
13 
14 published studies, as well as synthesize the findings to inform policy-level decisions. One 
15 
16 
17 of the major limitations to synthesizing the youth physical activity literature is the 
18 
19 numerous ways physical activity is measured. Objective measures of physical activity 
20 
21 
have largely been obtained using uniaxial accelerometers worn at the hip,(Stone, 
23 
24 Faulkner, & Buliung, 2013; Troiano et al., 2008) but comparability between studies has 
25 
26 
been limited due to the large range of MVPA cut-points available for use with 
27 
28 
29 accelerometer data.(Bornstein et al., 2011; Brazendale et al., 2015) The advent of new 
30 
31 technology and the growing popularity of the wrist wear-site only exacerbates the 
32 
33 
34 difficulties of comparing estimates of physical activity across studies. 
35 
36 
37 
38 
39 The GENEActiv, ActiGraph GT3X+ and ActiGraph GT9X Link sample and store raw 
40 
41 accelerations, rather than proprietary counts, and are designed for wrist-wear. The 
42 
43 
44 GENEActiv has grown in popularity as an objective measure of youth moderate-to- 
45 
46 vigorous physical activity (MVPA) since it was first introduced in 2008 and is most 
47 
48 
commonly used on the wrist. (Esliger et al., 2011) The ActiGraph GT3X+, worn on the 
50 
51 wrist, has been used in NHANES since 2011, and while estimates of physical activity 
52 
53 
intensity from these wrist-worn accelerometers have demonstrated strong reliability and 
54 
55 
56 validity, (Esliger et al., 2011; Phillips, Parfitt, & Rowlands, 2013) the estimates of 
1 
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4 physical activity from wrist-worn devices cannot be directly compared to estimates of 
5 
6 
7 physical activity from hip-worn devices. 
8 
9 
10 
11 
12 Two previous studies have addressed the issue of non-comparable estimates of physical 
13 
14 activity across published studies through the development of conversion equations, 
15 
16 
17 referred to as the Rosetta Stone (Bornstein, et al., 2011; Brazendale, et al., 2015). The 
18 
19 equations convert estimates of MVPA from widely used cutpoints from a single hip-worn 
20 
21 
physical activity monitoring device (i.e., ActiGraph accelerometers). The application of 
23 
24 these equations was illustrated in a subsequent study (Coelho et al. 2017) where 
25 
26 
published ActiGraph-derived estimates of MVPA for preschool-age children were 
27 
28 
29 “standardized” into a common cutpoint estimate of MVPA. This study illustrated that 
30 
31 when applying the Rosetta Stone equations, differences in the estimates of MVPA across 
32 
33 
34 studies could be improved from ~80 minutes/day (range 11.6 to 219) to ~14 minutes/day 
35 
36 (range 0.6 to 38.7). This reduced the differences in MVPA across studies due to the 
37 
38 
application of the varying cutpoints to distill ActiGraph data into minutes of MVPA. 
40 
41 
42 
43 
44 In the absence of a comprehensive database containing all accelerometer-derived raw 
45 
46 data files that could be standardized using a single data reduction procedure, the 
47 
48 
development of equating systems is necessary and should widely appeal to those seeking 
50 
51 to synthesize the growing body of literature on youth physical activity. While progress 
52 
53 
has been made towards this effort, existing equating systems are limited to only a single 
54 
55 
56 hip-worn device – ActiGraph accelerometer. We are unaware of any equating systems 
57 
58 that have been developed to compare estimates of MVPA across different wear-sites. A 
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4 previous study (Rowlands et al., 2016) made comparisons among wrist- and hip-worn 
5 
6 
7 accelerometer-derived MVPA and found that, depending on the data reduction procedure, 
8 
9 comparable estimates of minutes spent in MVPA could be obtained between the two 
10 
11 
placements.  However, this study did not provide a way to standardize previously 
13 
14 published group-level estimates of MVPA so numbers could be compared across 
15 
16 
different cut-points or placements. Therefore, the purpose of this study was to develop a 
17 
18 
19 series of Rosetta Stone conversion equations to compare estimates of MVPA derived 
20 
21 from accelerations measured at the wrist and from ActiGraph counts measured at the hip 
22 
23 
24 in elementary school-aged children. 
25 
26 
27 
28 
29 Methods 
30 
31 
32 
33 
34 This is a secondary data analysis using data from three studies: 1) 58 children, aged 10-12 
35 
36 
years, recruited from primary schools in South Australia (Rowlands et al., 2014); 2) 129 
37 
38 
39 children, aged 9-10 years, recruited from primary schools in Liverpool, UK (Fairclough 
40 
41 et al., 2016); 3) 81 children, aged 9-11 years, recruited from two primary schools in 
42 
43 
44 Liverpool, UK. The appropriate university research ethics committee approved each 
45 
46 study. Written informed consent and assent were obtained from the parents/guardians and 
47 
48 
children, respectively. Height was measured to the nearest 0.1 cm and body mass to the 
50 
51 nearest 0.1 kg. 
52 
53 
54 
55 
56 Free-living physical activity was measured by concurrent wear of the GENEActiv on the 
57 
58 
non-dominant wrist and the ActiGraph GT3X+ positioned above the right hip, on a belt 
1 
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49 
4 worn around the waist, for seven consecutive days. In study 1, children were requested to 
5 
6 
7 wear both monitors day and night, removing the hip-worn ActiGraph for water-based 
8 
9 activities only. In studies 2 and 3, children were requested to wear both monitors at all 
10 
11 
times except when sleeping or during water-based activities. 
13 
14 
15 
16 
17 The GENEActiv is a triaxial accelerometry-based activity monitor with a dynamic range 
18 
19 of +/- 8g (Gravity Estimator of Normal Everyday Activity, ActivInsights Ltd, 
20 
21 
Cambridgeshire, UK). The ActiGraph GT3X+ is a triaxial accelerometry-based activity 
23 
24 monitor with a dynamic range of +/- 6 g (ActiGraph LLC, Pensacola, FL, USA). Study 1: 
25 
26 
The GENEActivs were initialized to collect data at 87.5 Hz and data uploaded using 
27 
28 
29 GENEActiv PC software version 2.2. The ActiGraphs were initialized to collect data at 
30 
31 80 Hz and data uploaded using Actilife version 6.5.3. Data were collected between April 
32 
33 
34 and December 2012. Studies 2 and 3: The GENEActivs and ActiGraphs were both 
35 
36 initialized to collect data at 100 Hz and data uploaded using GENEActiv PC software 
37 
38 
version 2.2 and Actilife version 6.11.4, respectively. Study 2 data were collected between 
40 
41 January and May 2014 and study 3 data were collected in January and February 2015. 
42 
43 
44 
45 
46 GENEActiv .bin files were analyzed with R-package GGIR version 1.2-0 (http://cran.r- 
47 
48 
project.org).(van Hees et al., 2014; van Hees et al., 2013) Signal processing in GGIR 
50 
51 includes the following steps: 1. Autocalibration using local gravity as a reference;(van 
52 
53 
Hees, et al., 2014) 2. Detection of sustained abnormally high values; 3. Detection of non- 
54 
55 
56 wear; 4. Calculation of the average magnitude of dynamic acceleration, i.e. the vector 
57 
58 magnitude of acceleration corrected for gravity (Euclidean Norm 
1 
2 
3 
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37 
4 minus 1 g, ENMO) over user-defined s epochs: 
5 
6 
7 
8 
9 
ENMO  =  with negative values set to zero. 
10 
11 
12 
13 
14 
Study 1 captured data in 5 s epochs with studies 2 and 3 capturing data in 1 s epochs, 
15 
16 
17 thus, for study 1, ENMO was averaged over 5 s epochs; and for studies 2 and 3, ENMO 
18 
19 was averaged over 1 s epochs. 
20 
21 
22 
23 
24 
Files were excluded from all analyses if post-calibration error was greater than 0.02 g and 
25 
26 
27 individual days were classified as invalid and excluded if wear-time was insufficient (16 
28 
29 h for the 24 h protocol in study 1, 10 h for the waking wear protocol in studies 2 and 3). 
30 
31 
32 Detection of non-wear has been described in detail previously (See ‘Procedure for non- 
33 
34 wear detection’ in supplementary document to van Hees et al., 2013(van Hees, et al., 
35 
36 
2013)). In brief, non-wear is estimated based on the standard deviation and value range of 
38 
39 each axis, calculated for 60 min windows with 15-min moving increments. If for at least 
40 
41 
2 out of the 3 axes the SD is less than 13 mg or the value range is less than 50 mg the 
42 
43 
44 time window is classified as non-wear. The default non-wear setting was used, i.e. invalid 
45 
46 data were imputed by the average at similar timepoints on different days of the week. The 
47 
48 
49 time spent above the children’s wrist acceleration MVPA threshold of 200 mg published 
50 
51 by Hildebrand et al. (2014)(Hildebrand, VT, Hansen, & Ekelund, 2014) was calculated 
52 
53 
54 using the argument ‘ilevels’ from the GGIR package for comparison to widely used hip- 
55 
56 worn ActiGraph MVPA cut-points. 
57 
58 
1 
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3 
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34 
39 
4 ActiGraph data were analyzed using Actilife version 6.13.0. The raw.gt3x files were 
5 
6 
7 summarized into uniaxial (vertical) proprietary counts in 5 s epochs, resulting in four 
8 
9 ActiGraph files for analysis per participant. Non-wear was defined as 60 min of 
10 
11 
consecutive zero counts, with an allowance for 1-2 min of counts between 0 and 100 
13 
14 (Troiano et al., 2008). Individual days were classed as invalid and excluded if wear-time 
15 
16 
was insufficient (16 h for the 24 h protocol in study 1, 10 h for the waking wear protocol 
17 
18 
19 in studies 2 and 3). Each file was analyzed with four widely-used MVPA cut-points: very 
20 
21 low (1100 CPM (counts per minute), approximately equivalent to the cut-point for an 11 
22 
23 
24 y old (3 METs) using the age-specific criteria of the Freedson group, published by Trost 
25 
26 et al. (2002);(S. G. Trost et al., 2002) low (1680 CPM, Pate et al., 2006);(Pate, Almeida, 
27 
28 
29 McIver, Pfeiffer, & Dowda, 2006) medium (2296 CPM, Evenson et al., 2008);(Evenson, 
30 
31 Catellier, Gill, Ondrak, & McMurray, 2008) high (3200 CPM, Puyau et al., 
32 
33 
2002).(Puyau, Adolph, Vohra, & Butte, 2002) 
35 
36 
37 
38 
Consistent with established protocols, (Bornstein, et al., 2011; Brazendale, et al., 2015) 
40 
41 linear and non-linear regression models were used to develop conversion equations in a 
42 
43 
development group of 132 participants, approximately half of the sample size. (Snee, RD, 
44 
45 
46 1977) Age, gender, height, and weight were introduced as predictors and incorporated in 
47 
48 the final model if the proportion of variance (R2) increased by ≥1% and/or the absolute 
49 
50 
51 error in minutes and percent decreased by ≥1 minute or 1%, respectively. For the 
52 
53 equation cross-validation, the following procedures were used. First, the 100 participants 
54 
55 
56 were randomly selected, without replacement (i.e., a participant could not appear twice 
57 
58 within the same group), into 20 groups of 25 participants to conduct the group-level 20- 
1 
2 
3 
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12 
49 
4 fold cross-validation. Average estimates of group-level MVPA were calculated for each 
5 
6 
7 of the 20 groups. The equations converting GENEActiv wrist to ActiGraph hip and 
8 
9 ActiGraph hip to GENEActiv wrist were applied to the group-level means. Actual 
10 
11 
device-derived MVPA estimates were compared to the Rosetta Stone equation-estimated 
13 
14 MVPA. Differences, at the group-level, were calculated as the actual (i.e., device-derived 
15 
16 
estimates) minus the Rosetta Stone converted estimates of MVPA. Since the equations 
17 
18 
19 are designed to convert published group-level estimates rather than converting individual- 
20 
21 level data points, group-level validations were incorporated instead of individual-level 
22 
23 
24 validations. Bland Altman plots were created to illustrate the agreement between actual 
25 
26 and predicted MVPA estimates.(Bland & Altman, 1986) In the absence of an empirically 
27 
28 
29 derived range of acceptable error, ±10% was chosen and plotted to depict reasonable 
30 
31 differences between actual and predicted MVPA values. 
32 
33 
34 
35 
36 Results 
37 
38 
39 
40 
41 A summary of the sample characteristics and estimates of MVPA across devices and 
42 
43 
44 cutpoints is presented in Table 1. Scatter plots illustrating the relationship among wrist 
45 
46 GENEActiv and hip ActiGraph estimates of MVPA in the derivation sample are 
47 
48 
presented in Supplemental Figure 1. The Rosetta Stone equations converting 
50 
51 GENEActiv to ActiGraph and ActiGraph to GENEActiv are presented in Table 2. 
52 
53 
Overall, the proportion of variation explained ranged from R2 adj 0.52 to 0.56. This 
54 
55 
56 represented an absolute error in minutes ranging from 7.0 minutes/day up to 14.5 
57 
58 minutes/day or an absolute percent error ranging from 13.9% to 24.5%. The only models 
1 
2 
3 
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27 
32 
52 
57 
4 that included an additional independent explanatory variable were those converting 
5 
6 
7 GENEActiv with Pate ActiGraph cutpoints where age was included in the final models. 
8 
9 
10 
11 
12 --- Insert Table 1 and 2, and Supplemental Figure 1 here --- 
13 
14 
15 
16 
17 The results from the 20-fold cross-validation are presented in Table 3 and Supplemental 
18 
19 Figure 2. The average absolute minute difference and absolute percent difference of the 
20 
21 
22 conversions for ActiGraph converted into GENEActiv estimates of MVPA demonstrated 
23 
24 a high degree of comparability. Specifically, the average absolute differences in minutes 
25 
26 
ranged from 2.0 to 3.3 minutes/day, representing an average absolute percent error of 
28 
29 3.1% to 4.9%. Similar findings were observed when converting GENEActiv from 
30 
31 
ActiGraph, with the average absolute difference in minutes ranging from 1.1 to 9.0 
33 
34 minutes/day, representing an average absolute percent error ranging from 3.0% to 10.0%. 
35 
36 
37 
38 
39 --- Insert Table 3 and Supplemental Figure 2 here --- 
40 
41 
42 
43 
44 Discussion 
45 
46 
47 
48 
49 The purpose of this study was to develop conversion equations for comparing raw 
50 
51 
accelerations from wrist-worn GENEActiv and hip-worn ActiGraph derived estimates of 
53 
54 MVPA across published studies. Overall, the equations developed demonstrated a high 
55 
56 
degree of accuracy when applied to the group-level means of the derivation sample. This 
58 
59 suggests that those who wish to compare estimates of MVPA across published studies or 
1 
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22 
39 
49 
4 wish to combine estimates of MVPA analytically across studies using different devices, 
5 
6 
7 for instance within a quantitative meta-analysis, can utilize the developed Rosetta Stone 
8 
9 equations to standardize the estimates into a common metric of choice. 
10 
11 
12 
13 
14 As the options for objective monitoring devices continue to diversify, this renders direct 
15 
16 
17 comparisons of the estimates of physical activity across studies as problematic. This 
18 
19 problem has a long history in the field of physical activity, yet there are few 
20 
21 
solutions.(Kim, Beets, & Welk, 2012; S. Trost, 2007; Welk, McClain, & Ainsworth, 
23 
24 2012) Without a unifying consensus on the device and protocols for reducing activity 
25 
26 
intensity data, the field will continuously require some form of conversion procedures to 
27 
28 
29 facilitate direct comparisons across studies. The findings in this study provide evidence 
30 
31 that, with a moderately high degree of accuracy, comparisons can be made across studies 
32 
33 
34 reporting group-level estimates of either the GENEActiv or ActiGraph accelerometer 
35 
36 MVPA. This is important, especially as the use of the GENEActiv continues to increase, 
37 
38 
as well as, the expansion of the body of literature that has used or is currently using 
40 
41 ActiGraph accelerometers. 
42 
43 
44 
45 
46 There are several limitations that need attention. First, the sample for the development of 
47 
48 
equations while statistically appropriate in terms of size, may not be entirely 
50 
51 representative of the estimates of GENEActiv and ActiGraph physical activity for youth 
52 
53 
aged 9 to 12 years. Also, the equations are only applicable to ActiGraph hip studies that 
54 
55 
56 have used 5 second epochs – the epochs used to generate the hip worn ActiGraph 
57 
58 estimates of MVPA in this study. Thus, while the equations demonstrated a high degree 
1 
2 
3 
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12 
34 
4 of accuracy, additional equations may need to be developed to more accurately represent 
5 
6 
7 the “typical” activity levels of youth utilizing accelerations measured at the wrist and 
8 
9 ActiGraph counts measured at the hip. Ideally, a larger and international dataset, like the 
10 
11 
International Children Accelerometry Database (ICAD) used in the past to develop 
13 
14 Rosetta Stone equations,(Brazendale, et al., 2015) would be created that includes youth 
15 
16 
(≤18 years) simultaneously wearing two or more commonly used objective motion 
17 
18 
19 sensors. Further, the number of cutpoints evaluated herein does not represent the entirety 
20 
21 of the cutpoints that exist and are used in the published literature.(Kim, et al., 2012) Thus, 
22 
23 
24 additional Rosetta Stone conversion equations are needed to convert all possible 
25 
26 reduction methods.  Lastly, similar to the cutpoints employed to develop past Rosetta 
27 
28 
29 Stone equations,(Bornstein, et al., 2011; Brazendale, et al., 2015) it must be noted that the 
30 
31 cutpoints included in the present analysis were developed with some amount of error, and 
32 
33 
the prediction equations generated within this study bring an additional degree of error. 
35 
36 Despite this, the equations can be used to make comparisons more “similar” by 
37 
38 
standardizing them to a common metric, either MVPA derived from accelerations 
39 
40 
41 measured at the wrist or ActiGraph counts measured at the hip. This alone, should hold 
42 
43 value to those seeking to compare activity levels from studies utilizing these two devices. 
44 
45 
46 
47 
48 Conclusions 
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50 
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53 
In conclusion, the developed equations demonstrate a high level of consistency among 
54 
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56 device-derived MVPA and the group-level converted estimates of MVPA. The authors 
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58 recommend the use of these equations when comparing published estimates of MVPA 
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Tables 1-3 
Table 1. Total sample* moderate-to-vigorous physical activity and demographics 
Total Sample 
(N = 232) 
Derivation Sample 
(n = 132) 
Validation Sample 
(n = 100) 
Sex (% boys) 50% 50% 48% 
Age (years) 10.4 ±0.7 10.5 ±0.7 10.3 ±0.5 
Moderate-to-Vigorous Physical Activity (min d
-1
) M SD Range M SD Range M SD Range 
ActiGraph (hip-placed) 
Evenson 57.5 ±16.5 (23.0, 129.4) 60.4 ±17.5 (28.2, 129.4) 53.6 ±14.6 (23.0, 108.8) 
Pate 77.3 ±20.4 (33.1, 179.4) 81.9 ±21.6 (46.4, 179.4) 71.4 ±17.3 (33.1, 139.4) 
Puyau 38.3 ±12.7 (13.1, 86.6) 39.8 ±13.5 (13.1, 86.6) 36.3 ±11.4 (13.6, 78.8) 
Freedson 3MET 100.0 ±25.7 (44.5, 243.8) 107.0 ±27.2 (61.4, 243.8) 90.8 ±20.2 (44.5, 170.7) 
GENEActiv (wrist-placed) 
Hildebrand 69.3 ±24.1 (14.7, 140.8) 71.8 ±25.5 (14.7, 140.8) 66.3 ±22.1 (25.6, 127.0) 
*6 children removed due to missing data (e.g., age, sex); M= Mean, SD = Standard Deviation
-1 
Table 2. Prediction equations to transform MVPA estimates from wrist GENEActiv cutpoint (200 mg) into MVPA estimates from ActiGraph hip- 
based cutpoints 
Regression Equations* 
Absolute Error 
(minutes) 
Absolute Percent Error 
(%) 
Conversion Intercept 
MVPA 
(min d ) 
Age Adj. R2 Avg. Range Avg. Range 
GENEActiv to Evenson 23.73773 0.5110695 0.5589 9.0 (0.0, 45.7) 15.8 (0.0, 64.6) 
Evenson to GENEActiv 6.015253 1.088575 13.2 (0.0, 51.9) 23.9 (0.0, 147.6) 
GENEActiv to Pate 61.16497 0.8653035 -5.734111 0.5553 10.9 (0.1, 69.3) 13.9 (0.1, 50.0) 
Pate to GENEActiv -7.719662 0.6335803 4.199442 10.5 (0.0, 49.7) 24.5 (0.0, 166.2) 
GENEActiv to Puyau 15.40396 1.418296 0.5604 7.0 (0.0, 32.1) 19.6 (0.0, 101.7) 
Puyau to GENEActiv 11.31649 0.3961999 10.1 (0.0, 51.9) 21.6 (0.0, 129.6) 
GENEActiv to Freedson 3MET -53.98608 0.753542 10.17694 0.5154 14.5 (0.4, 83.7) 15.4 (0.4, 57.7) 
Freedson 3MET to GENEActiv 95.82304 0.671705 -9.13186 13.1 (0.1, 51.8) 21.6 (0.1, 226.7) 
*Covariates (e.g., age, sex) and non-linear terms (e.g., MVPA squared, square root of MVPA) were included in the model if statistically significant
(p<0.05) 
Table 3. Group level estimate (n = 25 per group) of GENEActiv minutes of MVPA compared to ActiGraph minutes of MVPA reduced using four 
cutpoints versus predicted minutes of MVPA using Rosetta Stone Equations 
GENEActiv from ActiGraph ActiGraph from GENEActiv 
Device Specific 
MVPA (mind-1)
Rosetta Stone 
Predicted 
MVPA 
GENEActiv vs. 
Predicted from 
Device Specific 
MVPA 
-1 
Rosetta Stone 
Predicted 
MVPA 
ActiGraph vs. 
Predicted from 
-1 (mind  ) -1 
Estimate (mind  ) ActiGraph Estimate (mind  ) GENEActiv 
Estimate 
Conversion GENEActiv 
ActiGraph to 
GENEActiv 
Difference 
(mind-1)
Percent 
Difference 
ActiGraph
Estimate 
GENEActiv to 
ActiGraph 
Difference 
(mind-1)
Percent 
Difference 
Evenson and GENEActiv 66.1 64.7 2.3 3.4% 54.0 57.5 3.6 6.7% 
Pate and GENEActiv 66.1 64.5 2.5 3.8% 71.8 77.2 5.4 7.6% 
Puyau and GENEActiv 66.1 67.1 2.0 3.1% 36.5 37.5 1.1 3.0% 
Freedson 3MET and GENEActiv 66.1 63.4 3.3 4.9% 91.2 100.2 9.0 10.0% 
a 
Average error in minutes and percent error represent the absolute errors. 
Figure 
Evenson MVPA Cutpoints (min d
-1
) Pate MVPA Cutpoints (min d
-1
)
Puyau MVPA Cutpoints (min d
-1
) Freedsom 3MET MVPA Cutpoints (min d
-1
)
Supplemental Figure 1. Scatter plot of GENEActiv and four ActiGraph estimates of MVPA in the derivation sample (n = 132) 
Note: Shaded area represents 95% confidence interval across line of best fit 
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Supplemental Figure 2. Bland Altman Plot comparing Rosetta Stone Converted and Unconverted GENEActiv 
estimates of MVPA to one of four ActiGraph MVPA cutpoints 
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